Tin tức & Cập nhật

Patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer (LG-IR-NMIBC) who achieved an initial complete response (CR) to UGN-102 treatment tend to remain event-free 24 months later, according to phase III ENVISION trial.

Hypofractionated proton therapy achieves an 8-month survival rate of 100 percent, preserves quality of life (QoL), and also lowers radiation exposure to the lungs and heart and reduces toxicity (eg, skin-related reactions) in Chinese patients with breast cancer compared with traditional photon radiotherapy, according to two first-of-its-kind studies in Asia conducted by researchers at the Hong Kong Sanatorium & Hospital (HKSH).

The use of combined oral contraceptives, progestogen-only pills, or hormonal intrauterine devices neither protects against nor contributes to the risk of colorectal cancer (CRC) in premenopausal women, according to a study.